Article Text

Download PDFPDF


Statistics from

Two errors have been noted in the paper by CJ Hawkey et al in the June issue (Incidence of gastroduodenal ulcers in patients with rheumatoid arthritis after 12 weeks of rofecoxib, naproxen, or placebo: a multicentre, randomised, double blind study. Gut 2003;52:820–6). On page 822, the lower 95% CI for the difference between rofecoxib and placebo (4.05), is given as 93.37 rather than 3.37. Also, in the key to fig 2, the dose of rofecoxib is given as 500 mg instead of 50 mg.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.